About MASSMEDICA
Sector
Industry
Headquarters
Warsaw
Website
Founded
2011
ISIN
PLMSMDC00018
FIGI
BBG00NX93N45
Massmedica SA engages in distributing implants and other medical materials which is used to treat diseases of the musculoskeletal system. It specializes in non-generic products. The firm offers products manufactured by European and American producers using the latest technologies in production process. The company was founded by Konrad Wiktor Lerski and Marek Stanislaw Mlodzianowski in May 2011 and is headquartered in Warsaw, Poland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MSM is 5.00 PLN — it hasn't changed in the past 24 hours. Watch MASSMEDICA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange MASSMEDICA stocks are traded under the ticker MSM.
MSM stock has risen by 0.40% compared to the previous week, the month change is a −18.03% fall, over the last year MASSMEDICA has showed a 100.00% increase.
MSM stock is 0.00% volatile and has beta coefficient of −0.93. Track MASSMEDICA stock price on the chart and check out the list of the most volatile stocks — is MASSMEDICA there?
Yes, you can track MASSMEDICA financials in yearly and quarterly reports right on TradingView.
Like other stocks, MSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MASSMEDICA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MASSMEDICA technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MASSMEDICA stock shows the buy signal. See more of MASSMEDICA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.